ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NIOX Niox Group Plc

71.00
1.00 (1.43%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Niox Group Plc LSE:NIOX London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.00 1.43% 71.00 70.00 72.20 72.20 70.00 71.60 387,393 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 33.3M 16.1M 0.0383 18.80 302.72M
Niox Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NIOX. The last closing price for Niox was 70p. Over the last year, Niox shares have traded in a share price range of 45.10p to 75.00p.

Niox currently has 420,442,112 shares in issue. The market capitalisation of Niox is £302.72 million. Niox has a price to earnings ratio (PE ratio) of 18.80.

Niox Share Discussion Threads

Showing 76 to 100 of 175 messages
Chat Pages: 7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
24/5/2023
17:54
Think it has to stay at that share price for so many consecutive days. Probably a conspiracy not to let that happen :)
earwacks
24/5/2023
09:12
Relentless rise.
Buyout earlier than expected?

badday
23/5/2023
20:43
From 4 years ago ....

Oxford, UK - 19 December 2019: Circassia ...announces that it has granted nil-cost options ("Options") today over 4,322,767 ordinary shares in the Company ("Ordinary Shares") to Ian Johnson, who was appointed as Executive Chairman of the Company on 5 December 2019, under the 2019 Performance Share Plan.

The Options have been granted at nil-cost and will vest on the third anniversary of the date of grant and are exercisable until the tenth anniversary of the date of grant. Vesting is subject to either the share price reaching 62.4p



Nearly there I would say .... He will be happy if it passes this hurdle!

thedudie
23/5/2023
18:15
Starting to pick up the last 2 days topped up yesterday
bc4
19/5/2023
09:37
After upbeat trading statement yesterday, two large buy trades @59p this morning yet price is down?!?
thaiger
18/5/2023
10:23
Typical market reaction to news. We have seen a rapid rise in the share price in recent weeks. Stockopedia has Niox a PE of 34. Not sure if that is still the case Stockopedia are tirelessly slow to update. So a bit of profit taking is inevitable. Cant deny I havnt thought about it myself, but just seems a bit too risky to duck out at this stage.the volume of buys in recent weeks has been quite relentless and some hefty stakes too.
Chris Mills Harwood trust said the 65p directors bonus would not happen under its own steam.Its only a few pence short now Chris! They get another tranche of bonus if it gets into the 70s. Its certainly not cheap, but on the other hand not that expensive for the sector. I dont who you could compare it to. Quite a stash of cash and more to come. More than enough for a decent divi or even a special.do they need that much to launch the home kit I wonder? At this stage I would prefer a predator to take away the decision about top slicing please! Gl all

earwacks
18/5/2023
08:48
Looks fairly predictable product demand going forward too and still have home test kit to launch. Asthma not going away anytime soon.
p1nkfish
18/5/2023
08:39
no idea why - stonking update - enough to take your breathe away..
edwardt
18/5/2023
08:31
muted reaction from the market
az4hr
18/5/2023
08:27
Valuation now?
p1nkfish
18/5/2023
07:41
I missed this bit cash balance up over 15% so full year we are looking at 30 mil or more

Gross margins continued to be robust, which together with the lower overheads as we exited 2022 meant that adjusted EBITDA for the first four months of the year was well ahead of management expectations.

The unaudited cash balance at 30 April 2023 was GBP22.3m (31 December 2022: GBP19.4m). Returns claims amounting to GBP1.1m relating to the discontinued business that were noted at the time of the preliminary results were settled in April.

bc4
18/5/2023
07:36
Don't forget the end goal here is to sell up. Comment here by me and snippet from brokers update:
mginvestor
18/5/2023
07:31
And no tax to pay from here to infinity looking at the previous losses.
p1nkfish
18/5/2023
07:29
Bloody hell, impressive.
Usually management expectations are kept internal and market expectations are lower to help give some safety margin on delivery to market.

In this case they beat management expectations!

p1nkfish
18/5/2023
07:17
Fantastic statement - a large revenue increase, EBITDA higher than expectations and dividends to come.
thedudie
18/5/2023
07:08
NIOX GROUP PLC
AGM Statement

Oxford, UK - 18 May 2023: NIOX Group plc (AIM: NIOX), a medical device company focused on point of care asthma diagnosis and management, is holding its Annual General Meeting today at the Hayakawa Building, Edmund Halley Road, Oxford Science Park. Oxford OX4 4GB.

Trading Update

We are pleased to report that our business has continued to perform well, with total revenues in the first 4 months of the year up 21% compared with the same period in 2022. Our core Clinical business grew strongly with revenues up 28% compared with the same period in 2022. EMEA has continued to experience strong growth, and our Asia markets have also improved significantly. In the USA, our relatively new distributor partners are starting to make an increasing contribution to revenues in the region, which were up 16% year to date compared with 2022.Ian Johnson, NIOX's Executive Chairman, said: "I am pleased to report a continuing strong trading performance in the year to date, reflecting the successful execution of our strategy. The effect of the growth in revenues, robust margins and the lower level of overheads means that adjusted EBITDA for the full year is now likely to be significantly higher than management expectations at the start of the year.

The Board believes that the cash generation and resources of the Group are now at a level where it is appropriate to commence the payment of a dividend. Further details of the timing and quantum of an initial dividend payment will be announced in due course.

It does not get any better than that great update

bc4
16/5/2023
15:57
INVA is US broke out a little too, late last week. Wonder if any correlation.
p1nkfish
16/5/2023
15:07
Taken from NIOX website

FeNO by NIOX®
Introducing a simple and easy way to transform your asthma care.By accurately assessing airway inflammation, FeNO testing can help improve asthma patient outcomes in one simple test, right at the point-of-care.
Trusted around the world
With over 45 million FeNO tests completed worldwide, NIOX® is trusted by thousands of healthcare professionals every day. Find out how FeNO by NIOX® can help make your asthma care easier.

bc4
16/5/2023
14:45
bc4 12 May '23 - 12:01 - 70 of 75
Yes looks like we could be on the move

We are on the move!

bc4
12/5/2023
15:39
You can buy blocks of 500 shares only at the moment
muffster
12/5/2023
13:10
Well you can sell 60,000 at 52.69p but you can't buy 5000 online, make of that what you will
bc4
12/5/2023
13:07
Yeah something is going on here for sure. May be an upcoming update ahead of expectations or tipped somewhere?
saadia110
12/5/2023
12:39
Something is happening for me, too quick.
deanowls
12/5/2023
12:11
Too early for a buyout? The ultimate goal.
Weekend tip, or just anticipation for positive update?

badday
12/5/2023
12:01
Yes looks like we could be on the move!
bc4
Chat Pages: 7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock